[Extrapyramidal adverse reactions to metoclopramide. A pharmacovigilance survey].

Frez, Carla; Awad, Yusfeye; Sánchez, Nilda; Silva, Andrea; Mercado, Beatriz; Marcotti, Constanza; Arévalo, Patricia; Apablaza, Karina; Fernández, Paula; Pérez, Daysi.
Rev Med Chil ; 146(7): 876-884, 2018 Jul.
Artigo em Espanhol | MEDLINE | ID: mdl-30534887

Documentos relacionados

  1. Metoclopramide for patients with intractable hiccups: a multicentre, randomised, controlled pilot study.
  2. Neuroleptic Malignant Syndrome Associated With Metoclopramide Use in a Boy: Case Report and Review of the Literature.
  3. High exposure compared with standard exposure to metoclopramide associated with a higher risk of parkinsonism: a nationwide population-based cohort study.
  4. IMAGES IN CLINICAL MEDICINE. An Acute Dystonic Reaction after Treatment with Metoclopramide.
  5. Movement Disorders From the Use of Metoclopramide and Other Antiemetics in the Treatment of Migraine.
  6. Gastroparesis, metoclopramide, and tardive dyskinesia: Risk revisited.
  7. Neuroleptic malignant syndrome associated with metoclopramide in a child.
  8. Reported time to onset of neurological adverse drug reactions among different age and gender groups using metoclopramide: an analysis of the global database Vigibase®.
  9. Intravenous metoclopramide in the treatment of acute migraines: A randomized, placebo-controlled trial.
  10. Safety and effect of metoclopramide to prevent pneumonia in patients with stroke fed via nasogastric tubes trial.